These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
42. mTOR activation protects liver from ischemia/reperfusion-induced injury through NF-κB pathway. Li Z; Zhang J; Mulholland M; Zhang W FASEB J; 2017 Jul; 31(7):3018-3026. PubMed ID: 28356345 [TBL] [Abstract][Full Text] [Related]
43. Alzheimer's dementia by circulation disorders: when trees hide the forest. Dotti CG; De Strooper B Nat Cell Biol; 2009 Feb; 11(2):114-6. PubMed ID: 19188916 [No Abstract] [Full Text] [Related]
44. Molecular interplay between hyperactive mammalian target of rapamycin signaling and Alzheimer's disease neuropathology in the NS-Pten knockout mouse model. Hodges SL; Reynolds CD; Smith GD; Jefferson TS; Nolan SO; Lugo JN Neuroreport; 2018 Sep; 29(13):1109-1113. PubMed ID: 29965873 [TBL] [Abstract][Full Text] [Related]
45. Nrf2 Deficiency Exacerbates Obesity-Induced Oxidative Stress, Neurovascular Dysfunction, Blood-Brain Barrier Disruption, Neuroinflammation, Amyloidogenic Gene Expression, and Cognitive Decline in Mice, Mimicking the Aging Phenotype. Tarantini S; Valcarcel-Ares MN; Yabluchanskiy A; Tucsek Z; Hertelendy P; Kiss T; Gautam T; Zhang XA; Sonntag WE; de Cabo R; Farkas E; Elliott MH; Kinter MT; Deak F; Ungvari Z; Csiszar A J Gerontol A Biol Sci Med Sci; 2018 Jun; 73(7):853-863. PubMed ID: 29905772 [TBL] [Abstract][Full Text] [Related]
46. Inhibition of mTOR by rapamycin abolishes cognitive deficits and reduces amyloid-beta levels in a mouse model of Alzheimer's disease. Spilman P; Podlutskaya N; Hart MJ; Debnath J; Gorostiza O; Bredesen D; Richardson A; Strong R; Galvan V PLoS One; 2010 Apr; 5(4):e9979. PubMed ID: 20376313 [TBL] [Abstract][Full Text] [Related]
47. TOR-inhibitors as gero-suppressors. Nikiforov M Aging (Albany NY); 2015 Dec; 7(12):1030-1. PubMed ID: 26796970 [No Abstract] [Full Text] [Related]
48. Metabotropic glutamate receptor 5 knockout reduces cognitive impairment and pathogenesis in a mouse model of Alzheimer's disease. Hamilton A; Esseltine JL; DeVries RA; Cregan SP; Ferguson SS Mol Brain; 2014 May; 7():40. PubMed ID: 24886239 [TBL] [Abstract][Full Text] [Related]
49. Disruption of mammalian target of rapamycin complex 1 in macrophages decreases chemokine gene expression and atherosclerosis. Ai D; Jiang H; Westerterp M; Murphy AJ; Wang M; Ganda A; Abramowicz S; Welch C; Almazan F; Zhu Y; Miller YI; Tall AR Circ Res; 2014 May; 114(10):1576-84. PubMed ID: 24687132 [TBL] [Abstract][Full Text] [Related]
50. A beta, aging, and Alzheimer's disease: a tale, models, and hypotheses. Chaney MO; Baudry J; Esh C; Childress J; Luehrs DC; Kokjohn TA; Roher AE Neurol Res; 2003 Sep; 25(6):581-9. PubMed ID: 14503011 [TBL] [Abstract][Full Text] [Related]
51. The role of the LncRNA-FA2H-2-MLKL pathway in atherosclerosis by regulation of autophagy flux and inflammation through mTOR-dependent signaling. Guo FX; Wu Q; Li P; Zheng L; Ye S; Dai XY; Kang CM; Lu JB; Xu BM; Xu YJ; Xiao L; Lu ZF; Bai HL; Hu YW; Wang Q Cell Death Differ; 2019 Sep; 26(9):1670-1687. PubMed ID: 30683918 [TBL] [Abstract][Full Text] [Related]
52. mTOR-dependent modulation of gastric nesfatin-1/NUCB2. Li Z; Xu G; Li Y; Zhao J; Mulholland MW; Zhang W Cell Physiol Biochem; 2012; 29(3-4):493-500. PubMed ID: 22508056 [TBL] [Abstract][Full Text] [Related]
53. Obesity in aging exacerbates blood-brain barrier disruption, neuroinflammation, and oxidative stress in the mouse hippocampus: effects on expression of genes involved in beta-amyloid generation and Alzheimer's disease. Tucsek Z; Toth P; Sosnowska D; Gautam T; Mitschelen M; Koller A; Szalai G; Sonntag WE; Ungvari Z; Csiszar A J Gerontol A Biol Sci Med Sci; 2014 Oct; 69(10):1212-26. PubMed ID: 24269929 [TBL] [Abstract][Full Text] [Related]
54. Geniposide effectively reverses cognitive impairment and inhibits pathological cerebral damage by regulating the mTOR Signal pathway in APP∕PS1 mice. Zhang Z; Gao W; Wang X; Zhang D; Liu Y; Li L Neurosci Lett; 2020 Feb; 720():134749. PubMed ID: 31935433 [TBL] [Abstract][Full Text] [Related]
55. Chlorogenic Acid Alleviates Aβ Gao L; Li X; Meng S; Ma T; Wan L; Xu S Drug Des Devel Ther; 2020; 14():1705-1716. PubMed ID: 32440096 [TBL] [Abstract][Full Text] [Related]
56. Benefit of Oleuropein Aglycone for Alzheimer's Disease by Promoting Autophagy. Cordero JG; García-Escudero R; Avila J; Gargini R; García-Escudero V Oxid Med Cell Longev; 2018; 2018():5010741. PubMed ID: 29675133 [TBL] [Abstract][Full Text] [Related]
57. Intranasal Insulin Increases Synaptic Protein Expression and Prevents Anesthesia-Induced Cognitive Deficits Through mTOR-eEF2 Pathway. Yu Q; Dai CL; Zhang Y; Chen Y; Wu Z; Iqbal K; Liu F; Gong CX J Alzheimers Dis; 2019; 70(3):925-936. PubMed ID: 31306126 [TBL] [Abstract][Full Text] [Related]
59. Activation of mammalian target of rapamycin induces lipid accumulation in the diaphragm of ventilated rats and hypoxia-treated C2C12 cells. Yu T; Wang M; Wen Y; Cao Y; Shen G; Jiang X; Wu J; Lu W; Jin X J Surg Res; 2018 May; 225():82-89. PubMed ID: 29605039 [TBL] [Abstract][Full Text] [Related]
60. Crosstalk between epigenetics and mTOR as a gateway to new insights in pathophysiology and treatment of Alzheimer's disease. Agarwal D; Kumari R; Ilyas A; Tyagi S; Kumar R; Poddar NK Int J Biol Macromol; 2021 Dec; 192():895-903. PubMed ID: 34662652 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]